These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2179836)

  • 1. Duration of live measles vaccine-induced immunity.
    Markowitz LE; Preblud SR; Fine PE; Orenstein WA
    Pediatr Infect Dis J; 1990 Feb; 9(2):101-10. PubMed ID: 2179836
    [No Abstract]   [Full Text] [Related]  

  • 2. [The strength of postvaccinal measles immunity in schoolchildren].
    Smorodinova IP; Miroshnikova NK; Sobolevskaia AA
    Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 4. [Control over the postvaccinal measles immunity status using the indirect hemagglutination test with lyophilized diagnostic agents].
    Sokhin AA; Sliuar' LI; Smorodinova IP; Rodomskaia FS; Makarova EN
    Tr Inst Im Pastera; 1981; 56():121-3. PubMed ID: 7187542
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serological study of postvaccinal measles immunity in the absence of a booster effect and in measles foci].
    Chudnaia LM; Fastovskaia BN; Shekhter AB; Orekhova GI; Dzhulaĭ AS
    Tr Inst Im Pastera; 1979; 53():71-5. PubMed ID: 262711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 8. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 10. [An increase in the effectiveness of the vaccinal prophylaxis of measles].
    Siniak KM
    Vrach Delo; 1989 Nov; (11):1-5. PubMed ID: 2609566
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles antibody in pregnant Argentinian women relative to vaccine-induced immunity and natural infection.
    Nates SV; Cumino A; Isa MB; Martínez LC; Naretto E; Medeot SI; Giordano MO; de Wolff CD
    Pediatr Infect Dis J; 1999 Oct; 18(10):937-9. PubMed ID: 10530595
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 13. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternally derived measles immunity in children of naturally infected and vaccinated mothers.
    Jenks PJ; Caul EO; Roome AP
    Epidemiol Infect; 1988 Oct; 101(2):473-6. PubMed ID: 3053223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The duration and intensity of measles immunity after a repeat inoculation against this infection].
    Bolotovskiĭ VM; Mikheeva IV; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):45-9. PubMed ID: 2385988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunofluorescence reaction in studying humoral immunity in parotitis].
    Iakovleva GS; Kaptsova TI; Bogomolova NN; Gordienko NM; Boriskin IuS
    Vopr Virusol; 1985; 30(4):488-91. PubMed ID: 3904211
    [No Abstract]   [Full Text] [Related]  

  • 17. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion rates and measles antibody titers induced by measles vaccine in Latin American children 6-12 months of age. Collaborative Study by the Ministries of Health of Brazil, Chile, Costa Rica, Ecuador, and the Pan American Health Organization.
    Bull Pan Am Health Organ; 1982; 16(3):272-85. PubMed ID: 7171892
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
    Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
    Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.